Sir, This is in reference to the article "syphilis incognito: Resurgence of the covert devil" published in your esteemed journal. [1] I read it with great interest and thoroughly agree with the authors' views. I would also like to share my experience. Recently, I came across a 30-year-old male, who was referred to our department on account of a reactive venereal disease research laboratory (VDRL) test (during a routine medical examination for job appointment in a foreign country). He showed his VDRL test reports from two laboratories, both of them reported him to be reactive, but none of them mentioned the titer. He was then treated with some injections, but no documentation was available. Therefore, a fresh sample was sent for VDRL (in serial dilutions), Treponema pallidum hemagglutination assay (TPHA) and human immunodeficiency virus (HIV). VDRL test was reactive up to 1:4 dilution, TPHA was positive, and HIV serology was negative. On history and examination, he revealed a history of unprotected sexual exposure few years back and was also suffering from recurrent episodes of herpes genitalis, which used to subside over 4-5 days without any treatment. Although no sign or symptom of syphilis was noted, the patient was diagnosed with syphilis of unknown duration and treated with three doses of benzathine penicillin. He is presently in regular follow-up.
I would like to focus on following points:
Screening
As there has been an increase in a number of asymptomatic cases or syphilis incognito, there should be no lacuna in the screening programs -whether antenatal, before surgery and blood donation. Furthermore, every patient presenting with any other sexually transmitted disease (STD), must be screened for syphilis. The very basic and golden rule in the context of STDs must not be forgotten -"one STD means possibility of another STD."
Ordering and interpreting venereal disease research laboratory test
• A nonreactive VDRL test: Most of the laboratories at present, do not perform the test in sequential dilution. This may result in false negative result due to prozone phenomenon. It is usually associated with secondary and early latent syphilis, early neurosyphilis, HIV coinfection, and pregnancy. [2, 3] Although the incidence is low (0.2%-2%), [2] one must be aware of this possibility. Furthermore, approximately, 30% of patients with late latent or late syphilis, nontreponemal tests are negative. [4] Therefore, a negative VDRL test must be interpreted with care, and the clinician should not refrain from ordering VDRL test in sequential dilution and specific treponemal tests to confirm the diagnosis. If, however, a definite diagnosis could not be established, it is always better to treat the patient (and partner) to further prevent the spread of this "covert devil" • A reactive VDRL test: Many laboratories report VDRL test simply as "reactive," without mentioning the titres. This defeats the very purpose of this test as it is not possible to follow-up the patient if the baseline titer is unknown. Such approach by the laboratories needs to be abolished, and the quantitative test must be performed at least for all "reactive" sera.
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This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. no similar lesions were found elsewhere in the body. Routine investigations were within normal limits, and the patient was seronegative for HIV. Systemic examination was unremarkable. Based on the clinical findings, differential diagnosis of Bowen's disease, psoriasis, extramammary Paget disease, and wart was made. Skin biopsy was performed from the lesion which showed marked epidermal hyperkeratosis, irregular acanthosis, scattered atypical keratinocytes, nuclear pleomorphism, and inflammatory infiltrate in the upper dermis [ Figures 2 and 3 ]. On the basis of clinicopathological correlation, a diagnosis of Bowen's disease was made, and the patient was treated with complete surgical excision followed by full-thickness skin grafting.
Bowen's disease affects skin and mucosa. Since it is a premalignant condition, if untreated, it may develop into invasive squamous cell carcinoma. [1] Clinically, it is manifested with a solitary erythematous scaly papule which gradually enlarges to form a crusted moist plaque. It is usually found on the sun-exposed sites, most
Solitary plaque in the perianal region
Sir, Bowen's disease is a premalignant dermatosis mostly affecting the sun-exposed sites. It usually develops in response to certain predisposing factors. We hereby report a case of an elderly gentleman with perianal Bowen's disease.
A 58-year-old farmer presented with a pruritic scaly patch over the lower back, present for the preceding 1 year. To start with, the lesion was a coin-sized patch, which gradually increased in size, and the patch began to ooze over the past 2 months. He sought treatment for this condition to multiple physicians, but there was no improvement. There was no history of pain, mucosal lesions, or any other skin lesions. On examination, a well-defined, erythematous, moist crusted plaque (7 cm × 5 cm) was present in the lumbosacral region [ Figure 1 ]. There was no locoregional lymphadenopathy, and
